Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID-19: Daily Top 10 Papers


  Liver Diseases

  Free Subscription


Articles published in Br J Surg

Retrieve available abstracts of 50 articles:
HTML format



Single Articles


    December 2021
  1. HOLMBERG M, Koppatz H, Jansson A, Hillingso JG, et al
    Secondary effects of the COVID-19 pandemic on surgical management of hepatopancreatobiliary malignancies in the Nordic capitals.
    Br J Surg. 2021 Dec 1. pii: 6447105. doi: 10.1093.
    PubMed    


    November 2021
  2. SRINIVASAN M, Shaji Mathew J, Mallick S, Nair K, et al
    Middle hepatic vein reconstruction in adult living donor liver transplantation: a randomized clinical trial.
    Br J Surg. 2021 Nov 25. pii: 6439950. doi: 10.1093.
    PubMed     Abstract available


  3. KABIR T, Tan ZZ, Syn NL, Wu E, et al
    Laparoscopic versus open resection of hepatocellular carcinoma in patients with cirrhosis: a meta-analysis.
    Br J Surg. 2021 Nov 10. pii: 6424997. doi: 10.1093.
    PubMed     Abstract available


  4. WELSCH T, Mussle B, Korn S, Sturm D, et al
    Pancreatoduodenectomy with or without prophylactic falciform ligament wrap around the hepatic artery for prevention of postpancreatectomy haemorrhage: a randomized clinical trial (PANDA trial).
    Br J Surg. 2021 Nov 8. pii: 6422748. doi: 10.1093.
    PubMed     Abstract available


    October 2021
  5. ZHONG JH, Xing BC, Zhang WG, Chan AW, et al
    Repeat hepatic resection versus radiofrequency ablation for recurrent hepatocellular carcinoma: a retrospective multicentre study.
    Br J Surg. 2021 Oct 13. pii: 6395264. doi: 10.1093.
    PubMed     Abstract available


  6. SNEIDERS D, Boteon APCS, Lerut J, Iesari S, et al
    Transarterial chemoembolization of hepatocellular carcinoma before liver transplantation and risk of post-transplant vascular complications: a multicentre observational cohort and propensity score-matched analysis.
    Br J Surg. 2021 Oct 6. pii: 6382003. doi: 10.1093.
    PubMed     Abstract available


    August 2021
  7. MIRANDE MD, Hernandez MC, Nagorney DM
    Corrigendum to: Ingested fishbone causing a hepatic abscess.
    Br J Surg. 2021 Aug 17. pii: 6353225. doi: 10.1093.
    PubMed    


  8. RATTI F, Aldrighetti L
    Commentary On "Laparoscopic Versus Open Resection Of Intrahepatic Cholangiocarcinoma: Nationwide Analysis".
    Br J Surg. 2021 Aug 2. pii: 6335751. doi: 10.1093.
    PubMed    


    July 2021
  9. ISONIEMI H, Uutela A, Nordin A, Lantto E, et al
    Centralized repeated resectability assessment of patients with colorectal liver metastases during first-line treatment: prospective study.
    Br J Surg. 2021;108:817-825.
    PubMed     Abstract available


  10. HOBEIKA C, Cauchy F
    Reply: Commentary on 'laparoscopic versus open resection of intrahepatic cholangiocarcinoma: nationwide analysis'.
    Br J Surg. 2021 Jul 16. pii: 6322942. doi: 10.1093.
    PubMed    


    June 2021
  11. WEI F
    Comment on: Laparoscopic versus open resection of intrahepatic cholangiocarcinoma: nationwide analysis.
    Br J Surg. 2021 Jun 14. pii: 6298428. doi: 10.1093.
    PubMed    


    May 2021
  12. LAYTON GR, Chung WY, Isherwood J, Fraser RE, et al
    Endoscopic retrograde cholangiopancreatography in the COVID era: considerations for hepatobiliary and pancreatic surgery units.
    Br J Surg. 2021 May 17. pii: 6277144. doi: 10.1093.
    PubMed    


  13. HOBEIKA C, Cauchy F
    Reply: Can laparoscopic approach improve quality of care of patients with resectable intrahepatic cholangiocarcinoma? (Comment on 'laparoscopic versus open resection of intrahepatic cholangiocarcinoma: nationwide analysis').
    Br J Surg. 2021 May 17. pii: 6277143. doi: 10.1093.
    PubMed    


    April 2021
  14. LIU Y, Chang W, Zhou B, Wei Y, et al
    Conventional transarterial chemoembolization combined with systemic therapy versus systemic therapy alone as second-line treatment for unresectable colorectal liver metastases: randomized clinical trial.
    Br J Surg. 2021;108:373-379.
    PubMed     Abstract available



  15. Ingested fishbone causing a hepatic abscess.
    Br J Surg. 2021 Apr 19. pii: 6238564. doi: 10.1093.
    PubMed    



  16. Snapshot quiz.
    Br J Surg. 2021;108:270.
    PubMed    


    March 2021
  17. TSILIMIGRAS DI, Pawlik TM
    Prognostication in hepatocellular carcinoma: is it a burden or a ticket?
    Br J Surg. 2021 Mar 18. pii: 6177466. doi: 10.1093.
    PubMed    


  18. LANG H
    Should all intrahepatic cholangiocarcinomas receive neoadjuvant chemotherapy before resection?
    Br J Surg. 2021 Mar 16. pii: 6173022. doi: 10.1093.
    PubMed    


  19. TROISI RI, Berardi G, Morise Z, Cipriani F, et al
    Laparoscopic and open liver resection for hepatocellular carcinoma with Child-Pugh B cirrhosis: multicentre propensity score-matched study.
    Br J Surg. 2021;108:196-204.
    PubMed     Abstract available


  20. TAKAICHI S, Tomimaru Y, Kobayashi S, Takeda Y, et al
    Drainage after laparoscopic liver surgery in the CSGO-HBP-004 study: propensity score-matched analysis.
    Br J Surg. 2021;108:e57-e58.
    PubMed    


  21. HEIL J, Korenblik R, Heid F, Bechstein WO, et al
    Preoperative portal vein or portal and hepatic vein embolization: DRAGON collaborative group analysis.
    Br J Surg. 2021 Mar 1. pii: 6154479. doi: 10.1093.
    PubMed     Abstract available


    January 2021
  22. TAKAYAMA T, Yamazaki S, Matsuyama Y, Midorikawa Y, et al
    Prognostic grade for resecting hepatocellular carcinoma: multicentre retrospective study.
    Br J Surg. 2021 Jan 31. pii: 6124821. doi: 10.1093.
    PubMed     Abstract available


  23. VAILAS M, Sotiropoulou M, Maroulis I
    Changing surgical practice in management of intrahepatic cholangiocarcinoma during the pandemic. Is bridging with systemic therapy safe for our patients?
    Br J Surg. 2021 Jan 27. pii: 6126379. doi: 10.1093.
    PubMed    


  24. HOBEIKA C, Cauchy F, Fuks D, Barbier L, et al
    Laparoscopic versus open resection of intrahepatic cholangiocarcinoma: nationwide analysis.
    Br J Surg. 2021 Jan 24. pii: 6118366. doi: 10.1093.
    PubMed     Abstract available


    October 2020
  25. LIN JY, Fang CH, Yang J
    Comment on: Right hepatic venous system variation in living donors: a three-dimensional CT analysis.
    Br J Surg. 2020 Oct 7. doi: 10.1002/bjs.11985.
    PubMed    


  26. HOBEIKA C, Soubrane O, Cauchy F
    Author response to: The intra-hepatic venous network in liver cirrhosis.
    Br J Surg. 2020 Oct 1. doi: 10.1002/bjs.11973.
    PubMed    


    September 2020
  27. WATANABE A, Harimoto N, Kogure K, Shirabe K, et al
    Author response to: Comment on: Right hepatic venous system variation in living donors: a three-dimensional CT analysis.
    Br J Surg. 2020 Sep 29. doi: 10.1002/bjs.11983.
    PubMed    


  28. MANENTI A, Roncati L, Manco G, Farinetti A, et al
    The intra-hepatic venous network in liver cirrhosis.
    Br J Surg. 2020 Sep 26. doi: 10.1002/bjs.11974.
    PubMed    


  29. HUO TI, Liu PH, Hsu CY
    Tumour burden score for hepatocellular carcinoma: Is it an authentic prognostic marker?
    Br J Surg. 2020 Sep 21. doi: 10.1002/bjs.11927.
    PubMed    


  30. TSILIMIGRAS DI, Pawlik TM
    Tumour Burden Score: An Authentic, Easy-To-Use Prognostic Marker for Hepatocellular Carcinoma.
    Br J Surg. 2020 Sep 21. doi: 10.1002/bjs.11926.
    PubMed    


  31. WATANABE A, Harimoto N, Kogure K, Shirabe K, et al
    Author response to: Comment on: Right hepatic venous system variation in living donors: a three-dimensional CT analysis.
    Br J Surg. 2020 Sep 16. doi: 10.1002/bjs.11825.
    PubMed    


  32. ANDEL D, Dassen MG, Reinders-Hut MTM, Peters NA, et al
    Surgical outcomes of major hepatectomy following "radiation lobectomy" for hepatic malignancies and insufficiently functional future liver remnant: initial experience.
    Br J Surg. 2020 Sep 16. doi: 10.1002/bjs.11828.
    PubMed    


  33. YAN J, Yang C, Bu J, Hu X, et al
    Comment on: Right hepatic venous system variation in living donors: a three-dimensional CT analysis.
    Br J Surg. 2020 Sep 13. doi: 10.1002/bjs.11826.
    PubMed    


    August 2020
  34. MOHAMED F, Kallioinen M, Braun M, Fenwick S, et al
    Author response to: NICE Guidelines: management of colorectal cancer metastases.
    Br J Surg. 2020;107:e358.
    PubMed    


    July 2020
  35. BAUM M, Fallowfield L, Farewell V, Macbeth F, et al
    NICE Guidelines: management of colorectal cancer metastases.
    Br J Surg. 2020 Jul 11. doi: 10.1002/bjs.11789.
    PubMed    


    June 2020
  36. ROMPIANESI G, Shankar S, Reddy S, Silva M, et al
    Caught in the crossfire: hepato-bilio-pancreatic cancer surgery in the midst of COVID-19.
    Br J Surg. 2020 Jun 22. doi: 10.1002/bjs.11764.
    PubMed    


  37. NEVERMANN NF, Hillebrandt KH, Knitter S, Ritschl PV, et al
    COVID-19 pandemic: implications on the surgical treatment of gastrointestinal and hepatopancreatobiliary tumours in Europe.
    Br J Surg. 2020 Jun 10. doi: 10.1002/bjs.11751.
    PubMed    


  38. WIGMORE SJ
    Advances in liver surgery.
    Br J Surg. 2020;107:788-789.
    PubMed    


  39. OLTHOF PB, Elfrink AKE, Marra E, Belt EJT, et al
    Volume-outcome relationship of liver surgery: a nationwide analysis.
    Br J Surg. 2020;107:917-926.
    PubMed     Abstract available


    May 2020
  40. MOHAMED F, Kallioinen M, Braun M, Fenwick S, et al
    Management of colorectal cancer metastases to the liver, lung or peritoneum suitable for curative intent: summary of NICE guidance.
    Br J Surg. 2020 May 9. doi: 10.1002/bjs.11609.
    PubMed    


    April 2020
  41. WATANABE A, Yoshizumi T, Harimoto N, Kogure K, et al
    Right hepatic venous system variation in living donors: a three-dimensional CT analysis.
    Br J Surg. 2020 Apr 26. doi: 10.1002/bjs.11602.
    PubMed     Abstract available


  42. ZHANG XP, Wang K, Gao YZ, Wei XB, et al
    Prognostic model for identifying candidates for hepatectomy among patients with hepatocellular carcinoma and hepatic vein invasion.
    Br J Surg. 2020 Apr 4. doi: 10.1002/bjs.11524.
    PubMed     Abstract available


  43. KOK END, Havenga K, Tanis PJ, de Wilt JHW, et al
    Multicentre study of short-course radiotherapy, systemic therapy and resection/ablation for stage IV rectal cancer.
    Br J Surg. 2020;107:537-545.
    PubMed     Abstract available


    March 2020
  44. WALLACE D, Cowling TE, Walker K, Suddle A, et al
    Liver transplantation outcomes after transarterial chemotherapy for hepatocellular carcinoma.
    Br J Surg. 2020 Mar 28. doi: 10.1002/bjs.11559.
    PubMed     Abstract available


  45. VIGANO L, Cimino M, Aldrighetti L, Ferrero A, et al
    Multicentre evaluation of case volume in minimally invasive hepatectomy.
    Br J Surg. 2020;107:443-451.
    PubMed     Abstract available


    February 2020
  46. KAWAGUCHI Y, Hasegawa K, Tzeng CD, Mizuno T, et al
    Performance of a modified three-level classification in stratifying open liver resection procedures in terms of complexity and postoperative morbidity.
    Br J Surg. 2020;107:258-267.
    PubMed     Abstract available


    January 2020
  47. SCHNITZBAUER AA
    Author response to: Beyond the scalpel - mortality after liver surgery in patients with liver metastases - time to rethink the indications: Total quality control and just culture for oncologic therapies urgently required!
    Br J Surg. 2020;107:149-150.
    PubMed    


  48. BODA-HEGGEMANN J, Hofheinz R, Gkika E, Brunner T, et al
    Beyond the scalpel - mortality after liver surgery in patients with liver metastases - time to rethink the indications.
    Br J Surg. 2020;107:149.
    PubMed    


    August 2019
  49. TANAKA M, Mihaljevic AL, Probst P, Heckler M, et al
    Meta-analysis of recurrence pattern after resection for pancreatic cancer.
    Br J Surg. 2019 Aug 27. doi: 10.1002/bjs.11295.
    PubMed     Abstract available


  50. GARLIPP B, Gibbs P, Van Hazel GA, Jeyarajah R, et al
    Secondary technical resectability of colorectal cancer liver metastases after chemotherapy with or without selective internal radiotherapy in the randomized SIRFLOX trial.
    Br J Surg. 2019 Aug 19. doi: 10.1002/bjs.11283.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Liver Diseases is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: